|
|
ACADIA Pharmaceuticals Presents Caregiver Burden Data at the International Congress of Non-Motor Dysfunctions in Parkinson’s Disease and Related Disorders
|
|
|
ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences
|
|
|
ACADIA Pharmaceuticals to Present at Jefferies 2014 Global Healthcare Conference on November 20, 2014
|
|
|
ACADIA Pharmaceuticals Reports Third Quarter 2014 Financial Results and Updates Timing of NUPLAZID™ NDA Submission
|
|
|
ACADIA Pharmaceuticals to Announce Third Quarter 2014 Financial Results on November 10, 2014
|
|
|
ACADIA Pharmaceuticals Receives FDA Breakthrough Therapy Designation for NUPLAZID™ (Pimavanserin) for Parkinson’s Disease Psychosis
|
|
|
ACADIA Pharmaceuticals Announces Trade Name NUPLAZID™ for Pimavanserin
|
|
|
ACADIA Pharmaceuticals Reports Second Quarter 2014 Financial Results
|
|
|
ACADIA Pharmaceuticals to Announce Second Quarter 2014 Financial Results on August 5, 2014
|
|
|
ACADIA Pharmaceuticals Announces Appointment of Stephen Davis as Executive Vice President, Chief Financial Officer and Chief Business Officer
|
|
|
ACADIA Pharmaceuticals to Present at the 9th Annual JMP Securities Healthcare Conference on June 24, 2014
|
|
|
ACADIA Pharmaceuticals to Present at the Jefferies 2014 Global Healthcare Conference on June 2, 2014
|
|
|
ACADIA Pharmaceuticals Reports First Quarter 2014 Financial Results
|
|
|
ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences
|
|
|
ACADIA Pharmaceuticals to Announce First Quarter 2014 Financial Results on May 6, 2014
|
|
|
ACADIA Pharmaceuticals to Present at the 13th Annual Needham Healthcare Conference on April 8, 2014
|
|
|
ACADIA Pharmaceuticals to Present at Upcoming Investor Conferences
|
|
|
ACADIA Pharmaceuticals Prices Public Offering of Common Stock
|
|
|
ACADIA Pharmaceuticals Announces Proposed Public Offering of Common Stock
|
|
|
ACADIA Pharmaceuticals Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2013
|
|
|
ACADIA Pharmaceuticals to Announce Fourth Quarter and Full Year 2013 Financial Results on February 27, 2014
|
